Neuropsicofarmacología - GIC 21/128
![Foto de Neuropsicofarmacología - GIC 21/128](/img/grupo.png)
![Foto de Hospital Universitario Virgen del Rocío](/img/noimage_org.png)
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublications in collaboration with researchers from Hospital Universitario Virgen del Rocío (12)
2023
-
Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
Medicina (Kaunas, Lithuania), Vol. 59, Núm. 8
2020
-
Comparative study between two european inception cohorts of patients with early systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 925-932
2019
-
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Translational Psychiatry, Vol. 9, Núm. 1
2018
-
Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort
Lupus, Vol. 27, Núm. 14, pp. 2253-2261
2017
-
Características clínicas al diagnóstico de una cohorte prospectiva de pacientes con lupus eritematoso sistémico atendidos en servicios de Medicina Interna españoles: estudio RELES
Revista Clinica Espanola, Vol. 217, Núm. 1, pp. 7-14
2016
-
First month prednisone dose predicts prednisone burden during the following 11 months: An observational study from the RELES cohort
Lupus Science and Medicine, Vol. 3, Núm. 1
-
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399
-
Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472
2012
-
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
Autoimmunity Reviews, Vol. 11, Núm. 5, pp. 357-364
-
Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox.
Current pharmaceutical design, Vol. 18, Núm. 32, pp. 5156-5164
2011
2010
-
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476